Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 3 Study of Galsulfase in MPS VI
NCT00067470Phase 3Completed
- Sponsor
- BioMarin Pharmaceutical
- Start
- Sep 2003
- Modality
- Replacement Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of galsulfase in mucopolysaccharidosis type VI, sponsored by BioMarin Pharmaceutical. Started Sep 2003; status: completed.
02
Drugs
galsulfase
03
Conditions
mucopolysaccharidosis type VI
Beyond the preview
Go deeper on NCT00067470.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00067470.